Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

ClinicalTrials.gov ID: NCT02358889

Public ClinicalTrials.gov record NCT02358889. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 4:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-masked, Multicenter, Active-controlled Study Evaluating Administration of Repeated Intravitreal Doses of hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Study identification

NCT ID
NCT02358889
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Iconic Therapeutics, Inc.
Industry
Enrollment
88 participants

Conditions and interventions

Interventions

  • hI-con1 Biological
  • ranibizumab Biological
  • Sham injection Other

Biological · Other

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Aug 31, 2016
Completion
Aug 31, 2016
Last update posted
Sep 23, 2020

2015 – 2016

United States locations

U.S. sites
48
U.S. states
21
U.S. cities
47
Facility City State ZIP Site status
Not listed Phoenix Arizona 85020
Not listed Phoenix Arizona 85021
Not listed Arcadia California 91007
Not listed Beverly Hills California 90211
Not listed Campbell California 95008
Not listed Glendale California 91203
Not listed Laguna Hills California 92653
Not listed Mountain View California 94040
Not listed Palm Desert California 92260
Not listed Palo Alto California 94303
Not listed San Francisco California 94109
Not listed Santa Ana California 92705
Not listed Golden Colorado 80401
Not listed Boynton Beach Florida 33426
Not listed Fort Myers Florida 33907
Not listed Panama City Florida 32405
Not listed Sarasota Florida 34233
Not listed Stuart Florida 34994
Not listed Winter Haven Florida 33907
Not listed Augusta Georgia 30909
Not listed Paducah Kentucky 42001
Not listed Baltimore Maryland 21209
Not listed Boston Massachusetts 02111
Not listed Detroit Michigan 48072
Not listed Jackson Michigan 49202
Not listed Royal Oak Michigan 48073
Not listed West Bloomfield Michigan 48322
Not listed Minneapolis Minnesota 55435
Not listed Las Vegas Nevada 89144
Not listed Bloomfield New Jersey 07003
Not listed Brooklyn New York 11223
Not listed Hauppauge New York 11788
Not listed Syracuse New York 13224
Not listed Ashland Oregon 97520
Not listed Portland Oregon 97210
Not listed Huntingdon Valley Pennsylvania 19006
Not listed Philadelphia Pennsylvania 19107
Not listed West Columbia South Carolina 29169
Not listed Kingsport Tennessee 37660
Not listed Abilene Texas 79606
Not listed Austin Texas 78705
Not listed Houston Texas 77030
Not listed McAllen Texas 78503
Not listed San Antonio Texas 78240
Not listed The Woodlands Texas 77384
Not listed Salt Lake City Utah 84107
Not listed Silverdale Washington 98383
Not listed Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02358889, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 23, 2020 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02358889 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →